By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics today announced that it has acquired a non-exclusive license to Innogenetics' hepatitis C virus genotyping patent estate in the US.

The deal includes an option to extend the license globally. Other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."

The US Food and Drug Administration has approved four molecularly targeted drugs this month, suggesting that personalized medicine has "turned a corner."

In Science this week: caution urged in use of gene drives, and more.